← Leaderboards
Jason Morgan Warram
University Of Alabama At Birmingham
$3,373,796
Attributed
$3,695,304
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,695,304 · 4
By mechanism
R37$2,675,967 · 1
R21$1,019,337 · 3
Top collaborators
- William Carroll1 shared
- Bharat Panuganti1 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Eben L Rosenthal$10,844,750
- Xun Ai$9,859,591
- Erwin G Van Meir$28,591,922
- Hope Amm$1,422,111
- William Carroll$308,706
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsTissuesOverexpressionDetectionResectedSpecimenCaringStandard Of CareOperative Surgical ProceduresTumorSurgeonFluorescenceExcisionEpidermal Growth Factor ReceptorClinical TrialsHead And Neck CancerProspectiveReceptor ExpressionOpen LabelFluorescence-Guided SurgeryDecision MakingDesignMicroscopicClinical Trials Design
Grant awards (9)
Reduction of Tumor-Positive Margins in Oncology Surgery$509,844
R37 · FY2025 · CA · contact PI
A Topical Plasmid-based Approach to Cervical Cancer Screening$170,805
R21 · FY2025 · CA · contact PI
Reduction of Tumor-Positive Margins in Oncology Surgery$517,409
R37 · FY2024 · CA · contact PI
Combination optical imaging to guide transoral laser microsurgery in larynx cancer$374,880
R21 · FY2024 · CA · contact PI
A Topical Plasmid-based Approach to Cervical Cancer Screening$205,516
R21 · FY2024 · CA · contact PI
Reduction of Tumor-Positive Margins in Oncology Surgery$538,275
R37 · FY2023 · CA · contact PI
Reduction of Tumor-Positive Margins in Oncology Surgery$547,188
R37 · FY2022 · CA · contact PI
Reduction of Tumor-Positive Margins in Oncology Surgery$563,251
R37 · FY2021 · CA · contact PI
Imaging Guided Surgery using Fluorescently Labeled Cetuximab$268,136
R21 · FY2015 · CA · contact PI